Skip to content

ORBIMED ADVISORS LLC

Reporting owner on Forms 3, 4 and 5, CIK 1055951.

ORBIMED ADVISORS LLC reported on 1 issuer in 59 filings, the latest a 13D/A filed 2026-10-08.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ADARx Pharmaceuticals, Inc. CIK 1802369director, 10% owner12026-09-30

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+10,690,53010,690,530Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+2,000,96212,691,492Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+769,60113,461,093Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+564,18714,025,280Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28P bought+300,249$1714,325,529Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+7,127,0197,127,019Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+1,333,9758,460,994Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+513,0678,974,061Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28C converted+256,4489,230,509Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28P bought+61,516$179,292,025Form 4
ADARx Pharmaceuticals, Inc. Common Stock2026-09-28P bought+588,235$17588,235Form 4
ADARx Pharmaceuticals, Inc. Series A Preferred Stock, derivative2026-09-28C converted-10,690,530$00Form 4
ADARx Pharmaceuticals, Inc. Series B Preferred Stock, derivative2026-09-28C converted-2,000,962$00Form 4
ADARx Pharmaceuticals, Inc. Series B-1 Preferred Stock, derivative2026-09-28C converted-769,601$00Form 4
ADARx Pharmaceuticals, Inc. Series C Preferred Stock, derivative2026-09-28C converted-564,187$00Form 4
ADARx Pharmaceuticals, Inc. Series A Preferred Stock, derivative2026-09-28C converted-7,127,019$00Form 4
ADARx Pharmaceuticals, Inc. Series B Preferred Stock, derivative2026-09-28C converted-1,333,975$00Form 4
ADARx Pharmaceuticals, Inc. Series B-1 Preferred Stock, derivative2026-09-28C converted-513,067$00Form 4
ADARx Pharmaceuticals, Inc. Series C Preferred Stock, derivative2026-09-28C converted-256,448$00Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
13D/A 0000947871-26-000931 AVBP2026-10-08
13D 0000947871-26-000917 ADARX PHARMACEUTICALS INC2026-10-02
Form 4 0000947871-26-000910 ADARx Pharmaceuticals, Inc.2026-09-30
13D 0000947871-26-000898 ELECTRA THERAPEUTICS INC2026-09-25
13F-HR 0001172661-26-003740 Quarter ended 2026-06-302026-08-14acceptance time not in the bulk data set
13F-HR 0001172661-26-002369 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001172661-26-001119 Quarter ended 2025-12-312026-02-17acceptance time not in the bulk data set
13F-HR 0001172661-25-005047 Quarter ended 2025-09-302025-11-14acceptance time not in the bulk data set
13F-HR 0001172661-25-003514 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001172661-25-002355 Quarter ended 2025-03-312025-05-15acceptance time not in the bulk data set
13F-HR 0001172661-25-001136 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001172661-24-005167 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001172661-24-003539 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001172661-24-002506 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001172661-24-001461 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001172661-23-004019 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001172661-23-003177 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001172661-23-002323 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001172661-23-001310 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001172661-22-002553 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001172661-22-001998 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-HR 0001172661-22-001456 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-HR 0001172661-22-000795 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001172661-21-002332 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001172661-21-001841 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001172661-21-001345 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-HR 0001172661-21-000786 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-HR 0001172661-20-002295 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-HR 0001172661-20-001859 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-HR 0001172661-20-001407 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-HR 0001172661-20-000859 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001172661-19-002352 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001172661-19-001883 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001172661-19-001382 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001172661-19-000868 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001172661-18-002168 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001172661-18-001660 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001172661-18-001239 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-HR 0001172661-18-000795 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-HR 0001172661-17-002146 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR 0001172661-17-001699 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001172661-17-001216 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0001172661-17-000766 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0001172661-16-004318 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0001172661-16-003893 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0001172661-16-003439 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0001172661-16-002937 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR/A 0001172661-15-002104 Quarter ended 2015-09-302015-11-18acceptance time not in the bulk data set
13F-HR 0001172661-15-001946 Quarter ended 2015-09-302015-11-13acceptance time not in the bulk data set
13F-HR/A 0001172661-15-001668 Quarter ended 2015-06-302015-08-20acceptance time not in the bulk data set
13F-HR 0001172661-15-001654 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0001172661-15-001221 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0001172661-15-000419 Quarter ended 2014-12-312015-02-13acceptance time not in the bulk data set
13F-HR 0001172661-14-001849 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR 0001172661-14-001491 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0001172661-14-001118 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR 0001172661-14-000746 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0001172661-13-001529 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0001172661-13-001218 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set